Veterinary Medicine Enrofloxacin Injection for Animal Use

• Varieties: Infectious Disease Prevention Medicine
• Component: Chemical Synthetic Drugs
• Type: The First Class
• Shipping Cost: Estimated freight per unit.: about shipping cost and estimated delivery time.
• Currency: US$
• Return&refunds: You can apply for a refund up to 30 days after receipt of the products.
• Model NO.: Enrofloxacin
• Pharmacodynamic Influential Factors: Animal Species
• Storage Method: Light Proof
• Veterinary Reg. No.: 150432523
• Animals: Poultry, Livestock, Dog, and Cat
• Indication and Usage: Fluoroquinolone Antibacterial Medicine
• Withdrawal Period: 14 Days for Cattle and Sheep, 10 Days for Pigs
• Characteristic: This Product Is a Colorless to Yellowish Clear Liq
• Main Content: Enrofloxacin
• Administration: Injection
• Transport Package: Box
• Specification: 100ml/bottle
• Trademark: SINDER
• Origin: Zhucheng City, China
• HS Code: 3004209099
• Production Capacity: 100000L/Year
• Package Size: 45.00cm * 31.00cm * 23.00cm
• Package Gross Weight: 9.300kg

Product Description

Instruction of Enrofloxacin Injection

Product Name: Ennuoshaxing Zhusheye
Generic Name: Enrofloxacin Injection
Main Components: Enrofloxacin
Characteristic: This product is a colorless to yellowish clear liquid
Pharmacologic action: Enrofloxacin is a kind of fluoroquinolone and a broad spectrum bactericide specially used for animal. It has good effect on Coli, Salmonella, Klebsiella, Brucella, Pasteurella, Actinobacillus Pleuropneumoniae, Erysipelas, Proteus, Serratia Marcescens, Corynebacterium Pyogenes, Bordetella Speticum, Staphylococcus Aureus, Mycoplasma, Chlamydia, etc., weak effect on Pseudomonas Aeruginosa, Streptococcus and Anaerobic bacteria. The antibacterial mechanism of this product is to inhibit bacterial DNA gyrase, interfere with the replication, transcription, repair and recombination of bacterial DNA, the bacteria cannot grow and reproduce normally and die.
Pharmacokinetics: This product is rapidly and completely absorbed by intramuscular injection, and the bioavailability is 91.9% in pigs and 82% in dairy cows. It is widely distributed in animals and can enter tissues and body fluids well. Except for cerebrospinal fluid, the drug concentration in almost all tissues is higher than that in plasma. Liver metabolism is mainly to remove the ethyl 7-piperazine ring to produce ciprofloxacin, followed by oxidation and glucuronic acid binding. It is mainly excreted from the kidney (excreted by the renal tubules and filtered by the glomerulus), and 15%~50% of it is excreted from the urine in the original form.  The elimination half-life varies greatly in different species of animals and different administration routes. The elimination half-life after intramuscular injection is 5.9 hours for cows, 9.9 hours for horses, 1.5~4.5 hours for sheep and 4.6 hours for pigs.
Drug Interactions:

1. This product has a synergistic effect when used in combination with aminoglycosides or broad-spectrum penicillin.
2. Heavy metal ions such as Ca2+, Mg2+, Fe3+ and Al3+ can chelate with this product and affect the absorption.
3. When combined with theophylline and caffeine, it can reduce the plasma protein binding rate, abnormally increase the concentration of theophylline and caffeine in the blood, and even cause symptoms of theophylline poisoning.
4. This product can inhibit liver drug enzymes, reduce the clearance rate of drug mainly metabolized in the liver, and increase the blood drug concentration.

Indication and usage: Fluoroquinolone antibacterial medicine. To be used for bacterial diseases and mycoplasma infection of livestock and poultry.
Administration and Dosage: Intramuscular injection: 0.025ml for cattle, sheep and pigs per 1kg body weight. 0.025-0.05ml for dogs, cats and rabbits. 1-2 times a day for 2-3 days.
Adverse Reaction:

1. Denaturate the cartilage of young animals, affect bone development and cause lameness & pain.
2. The reaction of digestive system includes vomiting, inappetence, diarrhea, etc.
3. Skin reactions include erythema, pruritus, urticaria and photo-sensitivity
4. Allergic reactions, ataxia and seizures were occasionally happened in dogs and cats

Precautions

1. It has potential stimulation on central system and induce epileptic seizures, not recommended for dogs with epilepsy.
2. Carnivorous animals and animals with poor renal function should be used with caution, and occasional crystalline urine my occur.
3. This product is not applicable to horse. Intramuscular injection has transient irritation.
4. This product is not applicable to dogs before 8 weeks old
5. The drug resistant strains of this product showed a increasing trend, and should not be used for long time under the Sub-therapeutic dose.

Withdrawal period: 14 days for cattle and sheep, 10 days for pigs and 14 days for rabbits.
Specification: 100ml:10g
Package: 100ml/bottle
Storage: dark airtight preservation.
Shelf Life: 2 years
China Veterinary Approval No.: S.Y.S.Z 150432523
Manufacture: Shandong Sinder Technology Co., Ltd

Shandong Sinder Technology Co., Ltd ('Sinder') founded in April 1999, has a wide range of animal health products. Sinder focus on Animal Health Products, Animal Vaccine, Antibodies, Antibiotics, Feed Additives, Chinese Herbal Product, Pet food, Elisa, and PCR test kit.

Sinder always persists in the core concept of 'The Relentless Pursuit of Increasing Customer Value. ' Based on the animal health to achieve a service provider for ecological construction of agriculture and animal husbandry. Support the efficient and sustainable development of agriculture and animal husbandry. Make food safer and rural areas better!

Sinder is a high-tech enterprise and one of the top 10 veterinary drug manufacturers in China and focusing on the animal health business. At the moment, the company has 35 GMP production lines, 1 CNAS laboratory, 3 national scientific research platforms, and 8 provincial scientific research platforms owned by Sinder.

Sinder has 4 R&D centers located in Qingdao, Zhucheng, and Beijing, China, and 1 laboratory in Silicon Valley in the United States. At present, the company has 1,535 employees including more than 200 masters or above and 18 doctors. Also, the company established extensive technical cooperation with several domestic and foreign scientific research institutes, animal health companies, and domestic veterinary medicine enterprises. Sinder has undertaken 57 national, provincial, and ministerial projects, gained 7 provincial and ministerial science and technology progress awards, presided over or participated in 23 national standards, obtained 23 new veterinary drug certificates(one 1st class new drug), and 60 authorized patents.